Glasdegib Completed Phase 1 Trials for Hepatic Impairment Basic Science

IndicationsStatusPurposePhase
CompletedBasic Science1
clinicaltrials.gov IdentifierTitleDrugs
NCT03627754A Study to Evaluate the Effect of Hepatic Impairment on the Pharmacokinetics of Glasdegib